A new study reveals that a common medication used to treat high blood pressure may also significantly reduce the risk of heart failure in patients with preserved ejection fraction, a condition where the heart muscle contracts normally but still struggles to pump enough blood. Researchers found that the drug, when administered to high-risk individuals, led to fewer hospitalizations and improved overall cardiac function. The findings challenge previous assumptions that such treatments were ineffective for this specific patient group. Experts suggest these results could reshape clinical guidelines for managing heart failure in the future.